Using analytics and bioassays to de-risk your mRNA LNP drug development programme
Pharmaceutical Technology
FEBRUARY 15, 2023
RNA has the potential to underpin breakthrough treatments for a wide variety of diseases, including many cancers, and transform medicine as we know it. More challenges arise with the formulation of the mRNA delivery agent, like lipid nanoparticles (LNPs). “At Outlook The era of mRNA-based genomic medicines is on the horizon.
130 
Let's personalize your content